HoPE (Hospice Preparation and Education)

Duke University

Overview

The investigator will conduct a two-site, randomized, controlled study of the HoPE (Hospice Preparation and Education) web-based tool versus usual care to assess: Technology usability (primary), study feasibility (secondary), user acceptability (secondary), and hospice service conversion rate (exploratory). Technology usability will be assessed through a one-time quantitative survey using established instruments. Study feasibility and user accessibility will be assessed through trial enrollment and retention alongside analytics assessing tool usage (e.g. time spent on each page of the website). Conversion rate is the percent of patients introduced to hospice who eventually enroll. The investigators will evaluate in an exploratory manner the differential effect of HoPE versus usual care.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE

Conditions

Hospice Care

Interventions

HoPE WebsiteOTHER

Educational website focused on hospice care

Eligibility

Sex: ALLMin age: 21 YearsMax age: 89 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Eligible for and referral made for home hospice services (Note: this excludes home palliative care, home infusion, home nursing, home physical therapy, and bridge services) * Aged between 21 and 89 * Capacity to give consent * Ability to speak and understand English

Locations (2)

Duke University Medical Center

Durham, North Carolina, United States

WakeMed Health & Hospitals

Raleigh, North Carolina, United States

Outcomes

Primary Outcomes

Technology usability as measured by System Usability Scale

To determine usability, the System Usability Scale will be administered to each participant in the intervention arm. As described by usability.gov: "The participant's scores for each question are converted to a new number, added together and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100. Though the scores are 0-100, these are not percentages and should be considered only in terms of their percentile ranking. Based on research, a SUS score above a 68 would be considered above average and anything below 68 is below average, however the best way to interpret your results involves "normalizing" the scores to produce a percentile ranking."

Time frame: At study completion, up to 4 months.

Secondary Outcomes

Study Feasibility as measured by enrollment efficiency

Enrollment efficiency will be measured by the percentage of patients approached who enroll in the study, with the goal of \>50% enrollment.

Time frame: At study completion, up to 4 months

Study Feasibility as measured by intervention completion

Intervention completion will be measured by the percentage of participants on the intervention arm who complete at least 50% of the modules within the intervention website, with a goal of \>50% of the participants.

Time frame: At study completion, up to 4 months

User Accessibility as measured by Net Promoter score

The Net Promoter scale is administered to participants in the intervention arm of the study only. This scale is an eleven-item likert scale assessing likelihood to recommend the intervention to a family member or friend. The percentage of participants who give a score of 0 through 6 is subtracted by the percentage of participants who give a score of 9 or 10 to give the overall Net Promoter score. This score is then compared to other scores of similar technologies.

Time frame: At study completion, up to 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.